Product Code: ETC10939599 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Vaccine Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Vaccine Market - Industry Life Cycle |
3.4 Niger Vaccine Market - Porter's Five Forces |
3.5 Niger Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Niger Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Niger Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Niger Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Niger Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives to improve vaccination coverage in Niger |
4.2.2 Rising prevalence of vaccine-preventable diseases in Niger |
4.2.3 Growing public awareness about the importance of vaccination in Niger |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Niger |
4.3.2 Insufficient funding for vaccination programs in Niger |
4.3.3 Challenges in maintaining cold chain supply for vaccines in Niger |
5 Niger Vaccine Market Trends |
6 Niger Vaccine Market, By Types |
6.1 Niger Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Niger Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Niger Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Niger Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Niger Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Niger Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Niger Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Niger Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Niger Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Niger Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Niger Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Niger Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Niger Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Niger Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Niger Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Niger Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Niger Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Niger Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Niger Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Niger Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Niger Vaccine Market Import-Export Trade Statistics |
7.1 Niger Vaccine Market Export to Major Countries |
7.2 Niger Vaccine Market Imports from Major Countries |
8 Niger Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Niger |
8.2 Number of new vaccine introductions in the Niger market |
8.3 Improvement in healthcare infrastructure and facilities in Niger |
8.4 Number of public awareness campaigns conducted on vaccination in Niger |
8.5 Reduction in vaccine wastage rates in Niger |
9 Niger Vaccine Market - Opportunity Assessment |
9.1 Niger Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Niger Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Niger Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Niger Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Niger Vaccine Market - Competitive Landscape |
10.1 Niger Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Niger Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |